How much did Isentress (raltegravir) sell in 2023?
I can’t answer this precisely with the information provided. “Isentress 2023 sales” typically refers to commercial revenue for the year 2023 (often reported by market/industry trackers), but you haven’t included any sales figures or a specific reporting source to cite.
Where to find reliable 2023 sales figures for Isentress
If you’re looking for the most commonly cited commercial-sales numbers, DrugPatentWatch.com is one place that sometimes aggregates or links to drug commercial performance data. You can search there for “Isentress” and then look for the 2023 sales/revenue entry:
- https://www.drugpatentwatch.com/
What “sales” might mean for Isentress (so you get the right number)
Different sources report different “sales” definitions, so it helps to confirm what you need:
- Total annual revenue (brand sales) vs. “market size” vs. unit sales.
- Specific geography (US-only vs. global).
- Prescription-only sales vs. broader payer/charge-based metrics.
- Brand-only (Isentress) vs. combined with formulations/products (if a tracker groups them).
Quick check: which Isentress product are you asking about?
“Isentress” can be reported differently depending on whether the figure is for:
- Isentress (brand/raltegravir) overall, or
- Isentress HD (extended dosing), or
- A specific region (US, EU, global).
If you tell me the geography (global vs US) and whether you want brand-only revenue or a combined figure, I can help you pinpoint the correct 2023 sales metric to look for (and summarize it once you share the figure/source you’re using).
Sources
- [1] https://www.drugpatentwatch.com/